Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST study

Switching to faricimab allowed for significantly extending the recurrence-free IVI interval and decreasing the proportion of exudative patients in this cohort. Significant extension was found in a wide range of patients, including those without a loading phase. Further controlled prospective studies are needed to assess the value of a loading phase when switching to faricimab. Safety outcomes were consistent with prior studies.

Authors

Institutions

Publication Details

Journal
Journal Français d Ophtalmologie
Published
2026-02-17
DOI
https://doi.org/10.1016/j.jfo.2026.104795
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST study

ML Le Lez, S. Faure, F. Mouriaux, C. Guyot et al.
Journal Français d Ophtalmologie
Retinal Diseases and Treatments
article

Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST study

ML Le Lez, S. Faure, F. Mouriaux, C. Guyot, V. Pipelart, Y. Maucourant, H. Masse, A. Posnic, J.-B. Ducloyer, A. Mainguy, H.-P. Jammes-Veaux, L. Bellot, M.-P. Posnic, A. George, M. Weber, C. Delhay, J.-F. Le Rouic, J.-P. Bellamy, N. Rousseau, B. Briend, D. Mazhar, B. Trinh Van Dam, M. Vaast, A. Bonissent, I. Fournier, A. Poinas, R.K. Khanna, R. Ferron, M. Benzerroug, M. Clement, T. Guillaumie, E. Le Pabic, A. Henry, P. Grimbert, O. Lebreton, Y. Bernard, G. Le Meur
article en

Abstract

Switching to faricimab allowed for significantly extending the recurrence-free IVI interval and decreasing the proportion of exudative patients in this cohort. Significant extension was found in a wide range of patients, including those without a loading phase. Further controlled prospective studies are needed to assess the value of a loading phase when switching to faricimab. Safety outcomes were consistent with prior studies.

Journal Français d OphtalmologieVol. 49(3)
Université de Tours (FR), Université d'Orléans (FR), Inserm (FR), Centre Hospitalier Universitaire de Nantes (FR), Université Rennes 2 (FR), Centre Hospitalier Universitaire de Tours (FR), Centre Hospitalier de Bretagne Sud (FR), Hôpital Bretonneau (FR), Centre Hospitalier de Saint-Brieuc (FR), Centre Hospitalier Universitaire d'Angers (FR), Centre Hospitalier du Mans (FR), IMT Atlantique (FR), Centre d'Investigation Clinique de Nantes (FR), Hôpital privé du Confluent (FR), Centre hospitalier universitaire d'Orléans (FR), Centre Hospitalier Départemental Vendée (FR), Laboratoire de Génie des Procédés – Environnement – Agro-alimentaire (FR), Genomic Vision (France) (FR), Centre Hospitalier Universitaire de Rennes (FR), Clinique Jules Verne (FR), Centre Hospitalier Saint-Nazaire (FR), Université de Rennes (FR), Cabinet Office (JP), Lantiq (Germany) (DE), École Supérieure de Commerce de Rennes (FR), Nantes Université (FR)
Openalex Percentile: Top 52%
Retinal Diseases and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.